Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent affecting red blood cell-fibrinogen interactions. ABS has been traditionally used in Anatolia as a hemostatic agent for centuries. ABS contains a standardized combination of the plants namely Glycyrrhiza glabra,...
Main Authors: | Rafiye Ciftciler, Ali Erdinc Ciftciler, Umit Yavuz Malkan, Ibrahim C Haznedaroglu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-02-01
|
Series: | SAGE Open Medicine |
Online Access: | https://doi.org/10.1177/2050312120907811 |
Similar Items
-
Hemostasis in Retropubic Radical Prostatectomy with Ankaferd BloodStopper®: A Case Report
by: Emre Hur, et al.
Published: (2009-08-01) -
Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
by: Cem Simsek, et al.
Published: (2017-07-01) -
A new candidate as a hemostatic agent for difficult situations during variceal bleeding: Ankaferd blood stopper
by: Ersan Ozaslan, et al.
Published: (2011-01-01) -
First Clinical Experience of Ankaferd BloodStopper as a Hemostatic Agent in Partial Nephrectomy
by: Emre Huri, et al.
Published: (2010-09-01) -
Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
by: Ahmet Koluman, et al.
Published: (2016-01-01)